Cellular mechanisms regulating tone in the chronically hypoxic pulmonary circulating are poorly defined. A growing body of evidence suggests alterated endothelial control of pulmonary vascular tone plays a critical role in pulmonary hypertension (PHT). We found inhibition of endothelial nitric oxide synthase (NOS) unmasks a potent vasoconstrictor stimulus in the hypoxic/hypertensive rat lung which is largely mediated by ET-1. These inhibitor studies also suggest that ET-1 is acting by stimulating Ca2+ influx through Ca2+ channels than the L-type channel, possibly low threshold voltage-gated Ca2+ channels. However, the mechanisms linking ET- 1, PA smooth muscle cells (SMC) membrane potential and Ca2+ influx in the hypertensive pulmonary circulation at the cellular level have not been defined. Additionally in question is the effect of chronic hypoxia on PA SMC ion channel expression and regulation. While it is known that chronic hypoxic PHT reduces macroscopic on PA SMCs, which might render the cells more depolarized, the full effect of chronic hypoxia on PA SMC ion channels and the mechanisms through which ion channel activation is altered are unknown. Results with NOS inhibitors in the hypertensive lung establish an important role for NO in modulating PA tone. While it has been generally assumed that NO acts through SMC cyclic guanosine monophosphate (cGMP) and protein kinase G (PKG) to phosphorylate target proteins, including ion channels, the majority of prior work has been done studying SMC from the normotensive circulation. Our preliminary data suggests that in the hypertensive pulmonary circulation a novel mechanisms of action for NO, independent of PKG-mediated phosphorylation, may play in important role in modulating basal vascular tone. Our four specific aims are to test the hypotheses that: 1) ET-1 causes membrane depolarization of hypertensive PA SMCs via inhibition of delayed rectifier K+ channels and activation of PA SMC non-selective cation channels. 2) Novel routes of Ca2+ entry in response to ET-1 and hypoxia develop, including low threshold voltage operated Ca2+ channels. 3) NO and cGMP modulate the activity of ET-1 regulated channels, including cyclic nucleotide gated (CNG) channels, in hypertensive resistance PA SMCs. And 4) The stimulus for alterations in PA SMC channel regulation (decreased K+ channels and novel Ca2+ channels) is either for both hypoxia and hemodynamic stress.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL014985-26
Application #
6272510
Study Section
Project Start
1998-04-01
Project End
1999-03-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
26
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Jiang, Xinguo; Nicolls, Mark R; Tian, Wen et al. (2018) Lymphatic Dysfunction, Leukotrienes, and Lymphedema. Annu Rev Physiol 80:49-70
Schäfer, Michal; Humphries, Stephen; Stenmark, Kurt R et al. (2018) 4D-flow cardiac magnetic resonance-derived vorticity is sensitive marker of left ventricular diastolic dysfunction in patients with mild-to-moderate chronic obstructive pulmonary disease. Eur Heart J Cardiovasc Imaging 19:415-424
D'Alessandro, Angelo; El Kasmi, Karim C; Plecitá-Hlavatá, Lydie et al. (2018) Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming. Antioxid Redox Signal 28:230-250
Karoor, Vijaya; Fini, Mehdi A; Loomis, Zoe et al. (2018) Sustained Activation of Rho GTPases Promotes a Synthetic Pulmonary Artery Smooth Muscle Cell Phenotype in Neprilysin Null Mice. Arterioscler Thromb Vasc Biol 38:154-163
Stenmark, Kurt R; Graham, Brian B (2018) Urocortin 2: will a drug targeting both the vasculature and the right ventricle be the future of pulmonary hypertension therapy? Cardiovasc Res 114:1057-1059
Madhavan, Krishna; Frid, Maria G; Hunter, Kendall et al. (2018) Development of an electrospun biomimetic polyurea scaffold suitable for vascular grafting. J Biomed Mater Res B Appl Biomater 106:278-290
Stenmark, Kurt R; Frid, Maria G; Graham, Brian B et al. (2018) Dynamic and diverse changes in the functional properties of vascular smooth muscle cells in pulmonary hypertension. Cardiovasc Res 114:551-564
Schäfer, Michal; Kheyfets, Vitaly O; Barker, Alex J et al. (2018) Reduced shear stress and associated aortic deformation in the thoracic aorta of patients with chronic obstructive pulmonary disease. J Vasc Surg 68:246-253
Graham, Brian B; Kumar, Rahul; Mickael, Claudia et al. (2018) Vascular Adaptation of the Right Ventricle in Experimental Pulmonary Hypertension. Am J Respir Cell Mol Biol 59:479-489
Wick, Marilee J; Harral, Julie W; Loomis, Zoe L et al. (2018) An Optimized Evans Blue Protocol to Assess Vascular Leak in the Mouse. J Vis Exp :

Showing the most recent 10 out of 148 publications